157 related articles for article (PubMed ID: 34190365)
1. An ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in cats.
Gilor C; Hulsebosch SE; Pires J; Bannasch MJ; Lancaster T; Delpero A; Ragupathy R; Murikipudi S; Zion T
J Vet Intern Med; 2021 Sep; 35(5):2123-2130. PubMed ID: 34190365
[TBL] [Abstract][Full Text] [Related]
2. Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs.
Hulsebosch SE; Pires J; Bannasch MJ; Lancaster T; Delpero A; Ragupathy R; Murikipudi S; Zion T; Gilor C
J Vet Intern Med; 2022 Jul; 36(4):1211-1219. PubMed ID: 35621084
[TBL] [Abstract][Full Text] [Related]
3. Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus.
Linari G; Fleeman L; Gilor C; Giacomelli L; Fracassi F
J Feline Med Surg; 2022 Feb; 24(2):168-176. PubMed ID: 34009061
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study.
Frias J; Chien J; Zhang Q; Chigutsa E; Landschulz W; Syring K; Wullenweber P; Haupt A; Kazda C
Lancet Diabetes Endocrinol; 2023 Mar; 11(3):158-168. PubMed ID: 36758572
[TBL] [Abstract][Full Text] [Related]
5. Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release.
Krämer AL; Riederer A; Fracassi F; Boretti FS; Sieber-Ruckstuhl NS; Lutz TA; Contiero B; Zini E; Reusch CE
J Vet Intern Med; 2020 Nov; 34(6):2287-2295. PubMed ID: 33001499
[TBL] [Abstract][Full Text] [Related]
6. Use of glargine and lente insulins in cats with diabetes mellitus.
Weaver KE; Rozanski EA; Mahony OM; Chan DL; Freeman LM
J Vet Intern Med; 2006; 20(2):234-8. PubMed ID: 16594577
[TBL] [Abstract][Full Text] [Related]
7. Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine.
Gottlieb S; Rand JS; Anderson ST
J Feline Med Surg; 2024 Apr; 26(4):1098612X241232546. PubMed ID: 38661475
[TBL] [Abstract][Full Text] [Related]
8. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
9. Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus.
Riederer A; Zini E; Salesov E; Fracassi F; Padrutt I; Macha K; Stöckle TM; Lutz TA; Reusch CE
J Vet Intern Med; 2016; 30(1):92-100. PubMed ID: 26700409
[TBL] [Abstract][Full Text] [Related]
10. Insulin Therapy in Small Animals, Part 2: Cats.
Fleeman L; Gilor C
Vet Clin North Am Small Anim Pract; 2023 May; 53(3):635-644. PubMed ID: 36906468
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
Pieber TR; Arfelt KN; Cailleteau R; Hart M; Kar S; Mursic I; Svehlikova E; Urschitz M; Haahr H
Diabetologia; 2023 Aug; 66(8):1413-1430. PubMed ID: 37308751
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus.
Scuderi MA; Ribeiro Petito M; Unniappan S; Waldner C; Mehain S; McMillian CJ; Snead EC
Domest Anim Endocrinol; 2018 Oct; 65():80-89. PubMed ID: 30015124
[TBL] [Abstract][Full Text] [Related]
13. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
Nelson RW; Henley K; Cole C;
J Vet Intern Med; 2009; 23(4):787-93. PubMed ID: 19566845
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats.
Nelson RW; Lynn RC; Wagner-Mann CC; Michels GM
J Am Vet Med Assoc; 2001 Jan; 218(1):38-42. PubMed ID: 11149712
[TBL] [Abstract][Full Text] [Related]
15. Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine.
Roomp K; Rand J
J Feline Med Surg; 2009 Aug; 11(8):668-82. PubMed ID: 19592286
[TBL] [Abstract][Full Text] [Related]
16. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
Hollander P; Cooper J; Bregnhøj J; Pedersen CB
Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
[TBL] [Abstract][Full Text] [Related]
17. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported Outcomes in Patients with Type 2 Diabetes Treated with Dulaglutide Added to Titrated Insulin Glargine (AWARD-9).
Yu M; Brunt KV; Milicevic Z; Varnado O; Boye KS
Clin Ther; 2017 Nov; 39(11):2284-2295. PubMed ID: 29110972
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
[TBL] [Abstract][Full Text] [Related]
20. Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study.
Guja C; Frías JP; Somogyi A; Jabbour S; Wang H; Hardy E; Rosenstock J
Diabetes Obes Metab; 2018 Jul; 20(7):1602-1614. PubMed ID: 29473704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
